Glucagon-like peptide-1 (GLP-1) agonists, initially indicated for treatment of T2D, are the newest FDA-approved AOMs
They take the time to fully explain everything to you and make you feel comfortable from the very beginning
If your primary concern is fatigue and low energy , B12 makes more sense
A 2024 BMJ cohort study found no increased risk of pulmonary aspiration during upper gastrointestinal endoscopy among adults with type 2 diabetes using GLP-1 receptor agonists compared with SGLT2 inhibitors, but GLP-1 use was associated with a higher risk of procedure discontinuation, possibly because of retained gastric contents
Whilst there is no specific pharmacological interaction listed between semaglutide and stimulant medications, cardiovascular considerations represent the most significant clinical concern when these treatments are used concurrently
In some cases, your doctor may suggest adjusting your dose or offer one of three anti-nausea medications to manage potential side effects